Japan External Trade Organization (JETRO), in partnership with UC San Diego’s Institute for the Global Entrepreneur (IGE), will host a JAPAN Innovation Luncheon on June 4th, the second day of BIO2024. Join us for a day of networking and meeting with innovative startups.
This is your exclusive chance to connect with key industry, academia, and government leaders from the U.S. and Japan. It's a “first look” at cutting-edge innovation in life science and biotechnology and an opportunity to explore U.S.-Japan collaborations.
This invitation-only event gathers professionals from the US and Japan biotech and life science industries and is the perfect opportunity to explore international collaborations. Hear keynotes from leading commercial, university, and government ecosystem partners in Japan and get "first looks" at unique, innovative startups.
Register now for the JETRO Innovation Luncheon - RSVP
Agenda:
11:30 am - Japan Innovation Luncheon & Showcase Opens
12:30 pm - Keynotes @ Main Hall
1:30 pm - Company presentations- Invitation to Collaborate
1:50 pm - Japan Showcase
2:30 pm - 4:00 pm Open for Private Meetings
A Few Participating Startups:
FerroptoCure - World’s first anti-cancer therapy that induces ferroptotic tumor death and ending drug resistance which plays a major role in cancer relapses & mortality. Currently, in Phase 1 clinical trials and seeking 20M in Series A funding.
FELIQS - FELIQS is a clinical-stage therapeutic company focused on ophthalmology. Our products target eye diseases that affect infants and age-related macular degeneration. FELIQS is raising $25 M Series A for upcoming clinical trials in the US and setting up full operations at JLABS in NYC.
Physiologas Technologies Inc.- Physiologas Technologies offers a portable, waterpipe-free hemodialysis device that allows patients to perform the procedure in the comfort of their homes. Our solution provides flexibility for the patient and frees them from the clinic, thus giving them a higher quality of life. We are looking are currently seeking $4M in funding..
Spine Chronicle Japan - Spine Chronicle Japan is developing spinal implants that improve surgical results in elderly patients with weaker bones. Our implants fortify the spine with minimally invasive surgery, leading to better recovery time. We are seeking $6M in investments for clinical trials and partners for business development in the US.
Vesica AI -Vesica AI is a Seed stage venture founded by Japan scientists and US Medtech team with non-dilutive funding on a mission to transform urology with its patented AI software platform. Vesica lesion detection system for bladder cancer is designed to reduce recurrence, improve patient outcomes, and save lives. Our published data has demonstrated the highest rates of sensitivity (95%) and specificity (98%) achieved to date, the key benchmarks of any medical imaging AI. Vesica recently won the inaugural Olympus APAC Innovation Program and seeks funding and partnerships.
About Japan External Trade Organization (JETRO)
JETRO, or the Japan External Trade Organization, is a government-related organization that promotes mutual trade and investment between Japan and the rest of the world. Initially established in 1958 to promote Japanese exports abroad, JETRO's core focus in the 21st century has shifted toward promoting foreign direct investment into Japan and helping small—to medium-sized Japanese firms maximize their global export potential. JETRO has tapped UC San Diego's Institute for the Global Entrepreneur to assist in this mission through its Beyond JAPAN Program. Beyond JAPAN plays a crucial role in facilitating international collaborations and showcasing the potential of Japanese startups.
FAQs
- Can I participate in the Investor preview if I am not an investor? Unfortunately, the session is limited to investors only.
- When is the deadline to RSVP? We will keep registration open until we hit capacity. Registration is highly recommended as it comes with a drink ticket.
- Who will be speaking? Local Japanese Government Officials, Biocom, UC San Diego Leadership